Regulatory Overhaul: Brazil’s ANVISA 2026-2027 Agenda

ha aggiunto una foto Wellness

2026-01-20 10:12:05 -

Effective January 1, 2026, Brazil’s regulatory body, ANVISA, has implemented its new "Regulatory Agenda" which prioritizes aesthetic devices. A key focus for 2026 is the regularization of products for dermal action and the revision of software-as-a-medical-device (SaMD) standards. This move is designed to purge the market of low-quality, "gray market" fillers and uncertified energy...

0 Commenti 0 condivisioni 483 Views 0 Anteprima